Abstract: A battery box and a battery pack are provided. The battery box includes a bottom plate and a side wall. The side wall and the bottom plate enclose a space for accommodating a battery and/or an electrical component. The battery box further includes a lifting column integrally formed with the side wall and a fixed sealing block sleeved on the lifting column. The bottom plate is located between the side wall and the fixed sealing block. The side wall is fixedly connected to the bottom plate through the fixed sealing block. A first sealing member for sealing a gap between the fixed sealing block and the bottom plate is arranged between the fixed sealing block and the bottom plate. The fixed sealing block is sealingly connected to the lifting column.

Abstract: A method includes putting a first package component into contact with a second package component. The first package component comprises a first dielectric layer including a first dielectric material, and the first dielectric material is a silicon-oxide-based dielectric material. The second package component includes a second dielectric layer including a second dielectric material different from the first dielectric material. The second dielectric material comprises silicon and an element selected from the group consisting of carbon, nitrogen, and combinations thereof. An annealing process is performed to bond the first dielectric layer to the second dielectric layer.

Abstract: The disclosure provides IL-7 fusion proteins as well as compositions comprising them. The disclosure further provides methods of treating and/or preventing lymphopenia or immunodeficiency in a subject, wherein the method includes administering a fusion protein as described herein.

Abstract: A semiconductor structure, comprising a redistribution layer (RDL) including a dielectric layer and a conductive trace within the dielectric layer; a first conductive member disposed over the RDL and electrically connected with the conductive trace; a second conductive member disposed over the RDL and electrically connected with the conductive trace; a first die disposed over the RDL; a second die disposed over the first die, the first conductive member and the second conductive member; and a connector disposed between the second die and the second conductive member to electrically connect the second die with the conductive trace, wherein the first conductive member is electrically isolated from the second die.

Abstract: A method includes forming a first dielectric layer, forming a first redistribution line comprising a first via extending into the first dielectric layer, and a first trace over the first dielectric layer, forming a second dielectric layer covering the first redistribution line, and patterning the second dielectric layer to form a via opening. The first redistribution line is revealed through the via opening. The method further includes forming a second via in the second dielectric layer, and a conductive pad over and contacting the second via, and forming a conductive bump over the conductive pad. The conductive pad is larger than the conductive bump, with a first center of conductive pad being offsetting from a second center of the conductive bump. The second via is further offset from the second center of the conductive bump.

Abstract: A method for fabricating magnetoresistive random-access memory cells (MRAM) on a substrate is provided. The substrate is formed with a magnetic tunneling junction (MTJ) layer thereon. When the MTJ layer is etched to form the MRAM cells, there may be metal components deposited on a surface of the MRAM cells and between the MRAM cells. The metal components are then removed by chemical reaction. However, the removal of the metal components may form extra substances on the substrate. A further etching process is then performed to remove the extra substances by physical etching.

Abstract: A method for preparing carbon black from pyrolysis char of waste tires by a molten salt thermal treatment and a product thereof are provided. The method includes heating one or two groups of a metal chloride salt group and a metal sulfate group to obtain a molten salt; adding pyrolysis char of waste tires into the molten salt and subjecting same to a molten salt thermal treatment under a preset reaction atmosphere; after the reaction is complete, separating the reaction product to obtain a secondary molten salt and treated pyrolysis char, washing the treated pyrolysis char with hot water and then drying same so as to obtain carbon black, and at the same time, recycling the secondary molten salt.

Abstract: Provided are a light source module and a backlight display module. The light source module includes a flexible printed circuit board and a plurality of side-emitting LEDs. The flexible printed circuit board extends along a central axis. The plurality of side-emitting LEDs are sequentially arranged along the central axis and bonded to the flexible printed circuit board, and a light-emitting surface of one side-emitting LED of the plurality of side-emitting LEDs is perpendicular to a bonding surface of the flexible printed circuit board.

Abstract: A wearable device includes a host, a first belt, a second belt, a circuit board, a cable, and an adjustment mechanism. The first belt, one end of which is connected to a first side of the host, has a cable holding part. One end of the second belt is connected to a second side of the host. The circuit board is disposed at an overlap of the first belt and the second belt. A first end and a second end opposite to each other of the cable are connected to the circuit board and the first side respectively, and a holding section of the cable is fixed to the cable holding part. The adjusting mechanism is disposed at an overlap of the first belt and the second belt to adjust an overlapping length of the first belt and the second belt.

Abstract: Apparatus, systems and methods for irrigating lands are disclosed. In one example, an irrigation system is disclosed. The irrigation system includes a gate and a microcontroller unit (MCU). The gate is configured for adjusting a water flow for irrigating a piece of land. The MCU is configured for controlling the gate to adjust the water flow based on environmental information related to the piece of land.

Abstract: The present disclosure provides compounds of Formulas (I), (II), and pharmaceutically acceptable salts thereof. The compounds described herein are useful in treating proliferative diseases, for example, cancer (e.g., lung cancer), and infectious diseases (e.g., bacterial infections).

Abstract: Technology is disclosed herein for mixed lockout verify. In a first programming phase, prior to a pre-determined data state completing verification, a no-lockout program verify is performed. After the pre-determined data state has completed verification, a lockout program verify is performed. The no-lockout verify may include charging all bit lines associated with the group to a sensing voltage to perform. The lockout verify may include selectively charging to the sensing voltage only bit lines associated with memory cells in the group to be verified. Bit lines associated with memory cells in the group that are not to be verified may be grounded to perform the lockout verify. The lockout verify saves considerable current and/or power. However, performing the lockout verify during the first programming phase may slow performance due to a need to scan the content in a remote set of data latches.

Abstract: The present invention provides a vertical feeding and wafer inserting integrated machine, comprising a rack and a silicon wafer transfer device provided on the rack; a carrying-transporting water tank for carrying and transporting silicon wafers is provided on one end of the rack; the rack is further provided with a feeding unit for conveying the silicon wafers in the carrying-transporting water tank to a silicon wafer transfer belt a wafer inserting unit for inserting the silicon wafers into wafer baskets is provided on one end, away from the feeding unit, of the silicon wafer transfer device, and a wafer basket arraying mechanism is provided on the other end of the wafer inserting unit; and a washing manipulator for transferring grouped wafer baskets to a washing procedure is further correspondingly provided on the rack.

Abstract: Disclosed herein are compositions and methods for the treatment of locally advanced or metastatic tumors. According to some embodiments, the compositions and methods involve the use of a hyaluronan-nimesulide conjugate, in combination with pyrimidine-base nucleotide analog.

Abstract: It is provided a method and system for calculating a turbulent mixing intensity, a computer device and a storage medium. The method comprises: performing denoising preprocess on ocean spatiotemporal coupled shear profile data information obtained by a turbulence profiler; constructing a multi-layer turbulent mixing network with topological attributes, where the network includes nodes and connecting edges; and each node is formed by fusion of four physical properties: time series, scale data, energy local intermittency measure and phase; recognizing a cross-scale transfer process of the turbulent energy according to a presence state of the connecting edges in the network; and performing parametric calculation of the turbulent mixing intensity according to the topological attributes of the multi-layer turbulent mixing network. According to the method, quantitative calculation of a turbulent energy transport intensity in an observation area of a full ocean depth profile is implemented.

Abstract: A method includes that an electronic device displays a first interface after detecting a first operation performed by a user on the electronic device. The first interface includes a first element and a second element. The electronic device displays at least one transition interface and then displays a second interface after detecting a second operation performed by the user on the first interface. The second interface includes the second element and a third element, the transition interface includes the second element, and the second element does not include an element in a status bar on the first interface, the transition interface, or the second interface.

Abstract: Described herein are methods of treating pyruvate kinase deficiency (PKD), sickle cell disease or thalassemia with mitapivat or a pharmaceutically acceptable salt thereof, or use of the drug for the treatment of these conditions, in combination with or in the absence of with a secondary drug, such as an inducer or an inhibitor of cytochrome P450. Various doses and dosing regimens of mitapivat in monotherapy and in concomitant medications are described.

Abstract: A shutter controller configured to control an operating rod of a shutter includes a controller housing, a clamping mechanism, and a driving mechanism. The controller housing includes a first housing and a second housing connected to each other, and the second housing is provided with a receiving cavity. The clamping mechanism is configured to clamp the operating rod and rotatably provided in the receiving cavity. The driving mechanism is provided in the first housing and is in transmission connection with the clamping mechanism, and the driving mechanism is configured to drive the clamping mechanism to rotate, thereby driving the operating rod to rotate.

Abstract: Disclosed are a method, apparatus, system and terminal device for measuring the total radiated power of an array antenna, and a non-transitory computer-readable storage medium. The method includes: dividing an array antenna to be measured into N antenna sub-arrays, the N being greater than or equal to 2; determining a sampling interval according to the sizes of the N antenna sub-arrays; determining sampling points according to the sampling interval; and determining the total radiated power of the entire array antenna according to the equivalent isotropic radiated power of the sampling points.

Abstract: Described herein are methods of treating pyruvate kinase deficiency (PKD), sickle cell disease or thalassemia with mitapivat or a pharmaceutically acceptable salt thereof, or use of the drug for the treatment of these conditions, in combination with or in the absence of with a secondary drug, such as an inducer or an inhibitor of cytochrome P450. Various doses and dosing regimens of mitapivat in monotherapy and in concomitant medications are described.